Małgorzata Drzewiecka

8PUBLICATIONS
32CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 14, 2024
Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells.

Gabriela Barszczewska-Pietraszek, Piotr Czarny, Małgorzata Drzewiecka

|Sep 28, 2023
Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells.

Małgorzata Drzewiecka, Dominika Jaśniak, Gabriela Barszczewska-Pietraszek

|Jun 28, 2023
Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor.

Małgorzata Drzewiecka, Anna Gajos-Michniewicz, Grażyna Hoser

|Jun 26, 2023
Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells.

Katherine Sullivan-Reed, Monika M Toma, Malgorzata Drzewiecka

|Jan 08, 2023
Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours.

Gabriela Barszczewska-Pietraszek, Małgorzata Drzewiecka, Piotr Czarny

Pageof 2